SCHEMBL3265754

SCHEMBL3265754

c1ccc2c(c1)CCC1CNCCN21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 19/20 1.00
HTR2B P41595 18/20 1.00
HTR2A P28223 5/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30396809 1.00 HTR2C (1.00) HTR2CHTR2BHTR2A
Hydrochloric Acid SCHEMBL7233743 0.98 HTR2C (0.97) HTR2CHTR2BHTR2A
SCHEMBL24187385 0.91 HTR2C (0.83) HTR2CHTR2BHTR2A
SCHEMBL691824 0.91 HTR2C (0.83) HTR2CHTR2BHTR2A
SCHEMBL15202984 0.87 HTR2C (0.77) HTR2CHTR2BHTR2A
SCHEMBL21788625 0.84 HTR2C (0.73) HTR2CHTR2BHTR2A
SCHEMBL5322262 0.83 HTR2C (0.73) HTR2CHTR2BHTR2A
SCHEMBL1366067 0.83 HTR2C (0.73) HTR2CHTR2BHTR2A
SCHEMBL692120 0.82 HTR2C (0.69) HTR2CHTR2BHTR2A
SCHEMBL19878681 0.79 HTR2C (1.00) HTR2CHTR2BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994020497-A1 PYRROLO-PYRIDINE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1994-09-15 WO claimed
CN-115720578-A Tricyclic derivative, preparation method and medical application thereof 深圳信立泰药业股份有限公司 2023-02-28 CN disclosed
WO-2022007866-A1 FUSED TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 深圳信立泰药业股份有限公司 2022-01-13 WO disclosed
EP-1551849-B1 TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN CO LLC (US) 2010-07-14 EP disclosed
WO-2005118591-A1 CONDENSED PIPERIDINE COMPOUNDS ACTING AS ADRENERGIC RECEPTOR ANTAGONISTS USEFUL IN THE TREATMENT OF PROSTATIC HYPERPLASIA AND LOWER URINARY SYMPTOMS RANBAXY LABORATORIES LIMITED (IN) 2005-12-15 WO disclosed
EP-1406631-A4 DOPAMINE RECEPTOR LIGANDS AND THERAPEUTIC METHODS BASED THEREON UNIV MICHIGAN (US) 2005-03-23 EP disclosed
EP-1406631-A2 DOPAMINE RECEPTOR LIGANDS AND THERAPEUTIC METHODS BASED THEREON THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2004-04-14 EP disclosed
US-6573377-B1 Antitumor agent capable of showing its efficacy even against 5- FU drug resistant tumors DAIICHI PHARMACEUTICALS CO., LTD. (JP) 2003-06-03 US disclosed
WO-2002100350-A2 DOPAMINE RECEPTOR LIGANDS AND THERAPEUTIC METHODS BASED THEREON THE REGENTS OF UNIVERSITY OF MICHIGAN (US) 2002-12-19 WO disclosed
US-5889010-A PSYCHOLOGICAL DISORDERS; UROGENITAL DISORDERS; COGNITION ACTIVATORS; NERVOUS SYSTEM DISORDERS; VISION DEFECTS; CONGESTIVE HEART FAILURE; DRUG ABRUSE; PARKINSON'S DISEASE;ANTIINFLAMMATORY AGENTS; ANTIALLERGENS PFIZER INC. (US) 1999-03-30 US disclosed
EP-0775118-A1 BENZIMIDAZOLE DERIVATIVES HAVING DOPAMINERGIC ACTIVITY PFIZER INC. (US) 1997-05-28 EP disclosed
US-5622950-A Pyrrolo-pyridine derivatives MERCK, SHARP & DOHME LTD. (GB) 1997-04-22 US disclosed
US-5576319-A Pyrrolo-pyridine derivatives MERCK, SHARP & DOHME LTD. (GB) 1996-11-19 US disclosed
WO-1996004250-A1 BENZIMIDAZOLE DERIVATIVES HAVING DOPAMINERGIC ACTIVITY PFIZER INC. (US) 1996-02-15 WO disclosed
US-5432177-A Pyrrolo-pyridine derivatives MERCK SHARPE & DOHME LTD. (GB) 1995-07-11 US disclosed
EP-0623618-A2 Pyrrolo-pyridine derivatives MERCK SHARP & DOHME LTD. (GB) 1994-11-09 EP disclosed
WO-1994020497-A1 PYRROLO-PYRIDINE DERIVATIVES MERCK SHARP & DOHME LIMITED (GB) 1994-09-15 WO disclosed
US-4681938-A Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis CIBA-GEIGY CORPORATION (US) 1987-07-21 US disclosed
US-4551450-A ANTITUBERCULOTIC AGENTS CIBA-GEIGY CORPORATION (US) 1985-11-05 US disclosed
EP-0135837-A2 Polycyclic hydrazones, process for their preparation, pharmacetical compositions thereof and their use CIBA-GEIGY AG (CH) 1985-04-03 EP disclosed